Home › Quitting Smoking (Tobacco Use Disorder) › South Carolina › Charleston
Quitting Smoking (Tobacco Use Disorder) clinical trials in Charleston, SC
6 studies for Quitting Smoking (Tobacco Use Disorder) are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches
RecruitingHealthy volunteers welcome
- Medical University of South Carolina, Charleston
Young Adult Tobacco/Nicotine and Cannabis Co-use
RecruitingHealthy volunteers welcome
- Medical University of South Carolina - Charleston, Charleston
E-cigarette Cessation in Adults Who Co-use Cannabis
RecruitingPhase 4Healthy volunteers welcome
- MUSC Charleston, Charleston
RTMS Targets Neural Circuits for Smoking Cessation
RecruitingHealthy volunteers welcome
- Medical University of South Carolina, Charleston
- Medical University of South Carolina, Charleston
Cannabis-Tobacco Co-Use Treatment Study
RecruitingPhase 3Healthy volunteers welcome
- Medical University of South Carolina - Charleston, Charleston
A Trial of Varenicline for E-cigarette Cessation
RecruitingPhase 2
- Hollings Cancer Center at MUSC (HCC), Charleston
Quitting Smoking (Tobacco Use Disorder) trials in other cities
- San Francisco, CA6 studies
- New Haven, CT4 studies
- Houston, TX4 studies
- Baltimore, MD4 studies
- Durham, NC4 studies
- Los Angeles, CA3 studies
- Newark, NJ3 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Non-Small Cell Lung Cancer16 studies
- Post-Traumatic Stress Disorder16 studies
- Cardiovascular Disease15 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Parkinson's Disease13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.